 | • レポートコード：GIR-107A12268 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、徐放性薬物のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。徐放性薬物の種類別市場規模（徐放性薬物、調節性薬物）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・徐放性薬物の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Mallinckrodt、Teva、Johnson & Johnson、Endo Pharmaceuticals、Purdue Pharma、Mylan、Hisamitsu Pharmaceutical、Sun Pharmaceutical Industries ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：徐放性薬物、調節性薬物 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・徐放性薬物の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・徐放性薬物のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・徐放性薬物のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・徐放性薬物の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・徐放性薬物の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Extended Release Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Extended Release Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Extended Release Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Extended Release Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sustained Release Drug
Controlled Release Drug
Market segment by Application, can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Market segment by players, this report covers
Pfizer
Mallinckrodt
Teva
Johnson & Johnson
Endo Pharmaceuticals
Purdue Pharma
Mylan
Hisamitsu Pharmaceutical
Sun Pharmaceutical Industries
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Extended Release Drug
1.2 Classification of Extended Release Drug by Type
1.2.1 Overview: Global Extended Release Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Extended Release Drug Revenue Market Share by Type in 2020
1.2.3 Sustained Release Drug
1.2.4 Controlled Release Drug
1.3 Global Extended Release Drug Market by Application
1.3.1 Overview: Global Extended Release Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Extended Release Drug Market Size & Forecast
1.5 Global Extended Release Drug Market Size and Forecast by Region
1.5.1 Global Extended Release Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Extended Release Drug Market Size by Region, (2016-2021)
1.5.3 North America Extended Release Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Extended Release Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Extended Release Drug Market Size and Prospect (2016-2026)
1.5.6 South America Extended Release Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Extended Release Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Extended Release Drug Market Drivers
1.6.2 Extended Release Drug Market Restraints
1.6.3 Extended Release Drug Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Extended Release Drug Product and Solutions
2.1.4 Pfizer Extended Release Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Mallinckrodt
2.2.1 Mallinckrodt Details
2.2.2 Mallinckrodt Major Business
2.2.3 Mallinckrodt Extended Release Drug Product and Solutions
2.2.4 Mallinckrodt Extended Release Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Mallinckrodt Recent Developments and Future Plans
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Extended Release Drug Product and Solutions
2.3.4 Teva Extended Release Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Teva Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Extended Release Drug Product and Solutions
2.4.4 Johnson & Johnson Extended Release Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Endo Pharmaceuticals
2.5.1 Endo Pharmaceuticals Details
2.5.2 Endo Pharmaceuticals Major Business
2.5.3 Endo Pharmaceuticals Extended Release Drug Product and Solutions
2.5.4 Endo Pharmaceuticals Extended Release Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Endo Pharmaceuticals Recent Developments and Future Plans
2.6 Purdue Pharma
2.6.1 Purdue Pharma Details
2.6.2 Purdue Pharma Major Business
2.6.3 Purdue Pharma Extended Release Drug Product and Solutions
2.6.4 Purdue Pharma Extended Release Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Purdue Pharma Recent Developments and Future Plans
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business
2.7.3 Mylan Extended Release Drug Product and Solutions
2.7.4 Mylan Extended Release Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Mylan Recent Developments and Future Plans
2.8 Hisamitsu Pharmaceutical
2.8.1 Hisamitsu Pharmaceutical Details
2.8.2 Hisamitsu Pharmaceutical Major Business
2.8.3 Hisamitsu Pharmaceutical Extended Release Drug Product and Solutions
2.8.4 Hisamitsu Pharmaceutical Extended Release Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Hisamitsu Pharmaceutical Recent Developments and Future Plans
2.9 Sun Pharmaceutical Industries
2.9.1 Sun Pharmaceutical Industries Details
2.9.2 Sun Pharmaceutical Industries Major Business
2.9.3 Sun Pharmaceutical Industries Extended Release Drug Product and Solutions
2.9.4 Sun Pharmaceutical Industries Extended Release Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Sun Pharmaceutical Industries Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Extended Release Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Extended Release Drug Players Market Share
3.2.2 Top 10 Extended Release Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Extended Release Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Extended Release Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Extended Release Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Extended Release Drug Revenue Market Share by Application (2016-2021)
5.2 Extended Release Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Extended Release Drug Revenue by Type (2016-2026)
6.2 North America Extended Release Drug Revenue by Application (2016-2026)
6.3 North America Extended Release Drug Market Size by Country
6.3.1 North America Extended Release Drug Revenue by Country (2016-2026)
6.3.2 United States Extended Release Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Extended Release Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Extended Release Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Extended Release Drug Revenue by Type (2016-2026)
7.2 Europe Extended Release Drug Revenue by Application (2016-2026)
7.3 Europe Extended Release Drug Market Size by Country
7.3.1 Europe Extended Release Drug Revenue by Country (2016-2026)
7.3.2 Germany Extended Release Drug Market Size and Forecast (2016-2026)
7.3.3 France Extended Release Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Extended Release Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Extended Release Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Extended Release Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Extended Release Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Extended Release Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Extended Release Drug Market Size by Region
8.3.1 Asia-Pacific Extended Release Drug Revenue by Region (2016-2026)
8.3.2 China Extended Release Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Extended Release Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Extended Release Drug Market Size and Forecast (2016-2026)
8.3.5 India Extended Release Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Extended Release Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Extended Release Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Extended Release Drug Revenue by Type (2016-2026)
9.2 South America Extended Release Drug Revenue by Application (2016-2026)
9.3 South America Extended Release Drug Market Size by Country
9.3.1 South America Extended Release Drug Revenue by Country (2016-2026)
9.3.2 Brazil Extended Release Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Extended Release Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Extended Release Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Extended Release Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Extended Release Drug Market Size by Country
10.3.1 Middle East & Africa Extended Release Drug Revenue by Country (2016-2026)
10.3.2 Turkey Extended Release Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Extended Release Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Extended Release Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Extended Release Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Extended Release Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Extended Release Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Extended Release Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Extended Release Drug Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Extended Release Drug Product and Solutions
Table 9. Pfizer Extended Release Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Mallinckrodt Corporate Information, Head Office, and Major Competitors
Table 11. Mallinckrodt Major Business
Table 12. Mallinckrodt Extended Release Drug Product and Solutions
Table 13. Mallinckrodt Extended Release Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Teva Corporate Information, Head Office, and Major Competitors
Table 15. Teva Major Business
Table 16. Teva Extended Release Drug Product and Solutions
Table 17. Teva Extended Release Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 19. Johnson & Johnson Major Business
Table 20. Johnson & Johnson Extended Release Drug Product and Solutions
Table 21. Johnson & Johnson Extended Release Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Endo Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Endo Pharmaceuticals Major Business
Table 24. Endo Pharmaceuticals Extended Release Drug Product and Solutions
Table 25. Endo Pharmaceuticals Extended Release Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Purdue Pharma Corporate Information, Head Office, and Major Competitors
Table 27. Purdue Pharma Major Business
Table 28. Purdue Pharma Extended Release Drug Product and Solutions
Table 29. Purdue Pharma Extended Release Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Mylan Corporate Information, Head Office, and Major Competitors
Table 31. Mylan Major Business
Table 32. Mylan Extended Release Drug Product and Solutions
Table 33. Mylan Extended Release Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Hisamitsu Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 35. Hisamitsu Pharmaceutical Major Business
Table 36. Hisamitsu Pharmaceutical Extended Release Drug Product and Solutions
Table 37. Hisamitsu Pharmaceutical Extended Release Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Sun Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors
Table 39. Sun Pharmaceutical Industries Major Business
Table 40. Sun Pharmaceutical Industries Extended Release Drug Product and Solutions
Table 41. Sun Pharmaceutical Industries Extended Release Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Extended Release Drug Revenue (USD Million) by Players (2019-2021)
Table 43. Global Extended Release Drug Revenue Share by Players (2019-2021)
Table 44. Breakdown of Extended Release Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Extended Release Drug Players Head Office, Products and Services Provided
Table 46. Extended Release Drug Mergers & Acquisitions in the Past Five Years
Table 47. Extended Release Drug New Entrants and Expansion Plans
Table 48. Global Extended Release Drug Revenue (USD Million) by Type (2016-2021)
Table 49. Global Extended Release Drug Revenue Share by Type (2016-2021)
Table 50. Global Extended Release Drug Revenue Forecast by Type (2021-2026)
Table 51. Global Extended Release Drug Revenue by Application (2016-2021)
Table 52. Global Extended Release Drug Revenue Forecast by Application (2021-2026)
Table 53. North America Extended Release Drug Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Extended Release Drug Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Extended Release Drug Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Extended Release Drug Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Extended Release Drug Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Extended Release Drug Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Extended Release Drug Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Extended Release Drug Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Extended Release Drug Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Extended Release Drug Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Extended Release Drug Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Extended Release Drug Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Extended Release Drug Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Extended Release Drug Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Extended Release Drug Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Extended Release Drug Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Extended Release Drug Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Extended Release Drug Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Extended Release Drug Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Extended Release Drug Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Extended Release Drug Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Extended Release Drug Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Extended Release Drug Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Extended Release Drug Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Extended Release Drug Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Extended Release Drug Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Extended Release Drug Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Extended Release Drug Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Extended Release Drug Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Extended Release Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Extended Release Drug Picture
Figure 2. Global Extended Release Drug Revenue Market Share by Type in 2020
Figure 3. Sustained Release Drug
Figure 4. Controlled Release Drug
Figure 5. Extended Release Drug Revenue Market Share by Application in 2020
Figure 6. Hospital Pharmacy Picture
Figure 7. Retail Pharmacy Picture
Figure 8. Online Pharmacy Picture
Figure 9. Global Extended Release Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Extended Release Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Extended Release Drug Revenue Market Share by Region (2016-2026)
Figure 12. Global Extended Release Drug Revenue Market Share by Region in 2020
Figure 13. North America Extended Release Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Extended Release Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Extended Release Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Extended Release Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Extended Release Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Extended Release Drug Market Drivers
Figure 19. Extended Release Drug Market Restraints
Figure 20. Extended Release Drug Market Trends
Figure 21. Pfizer Recent Developments and Future Plans
Figure 22. Mallinckrodt Recent Developments and Future Plans
Figure 23. Teva Recent Developments and Future Plans
Figure 24. Johnson & Johnson Recent Developments and Future Plans
Figure 25. Endo Pharmaceuticals Recent Developments and Future Plans
Figure 26. Purdue Pharma Recent Developments and Future Plans
Figure 27. Mylan Recent Developments and Future Plans
Figure 28. Hisamitsu Pharmaceutical Recent Developments and Future Plans
Figure 29. Sun Pharmaceutical Industries Recent Developments and Future Plans
Figure 30. Global Extended Release Drug Revenue Share by Players in 2020
Figure 31. Extended Release Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Extended Release Drug Revenue Market Share in 2020
Figure 33. Global Top 10 Players Extended Release Drug Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Extended Release Drug Revenue Share by Type in 2020
Figure 36. Global Extended Release Drug Market Share Forecast by Type (2021-2026)
Figure 37. Global Extended Release Drug Revenue Share by Application in 2020
Figure 38. Global Extended Release Drug Market Share Forecast by Application (2021-2026)
Figure 39. North America Extended Release Drug Sales Market Share by Type (2016-2026)
Figure 40. North America Extended Release Drug Sales Market Share by Application (2016-2026)
Figure 41. North America Extended Release Drug Revenue Market Share by Country (2016-2026)
Figure 42. United States Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Extended Release Drug Sales Market Share by Type (2016-2026)
Figure 46. Europe Extended Release Drug Sales Market Share by Application (2016-2026)
Figure 47. Europe Extended Release Drug Revenue Market Share by Country (2016-2026)
Figure 48. Germany Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Extended Release Drug Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Extended Release Drug Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Extended Release Drug Revenue Market Share by Region (2016-2026)
Figure 56. China Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Extended Release Drug Sales Market Share by Type (2016-2026)
Figure 63. South America Extended Release Drug Sales Market Share by Application (2016-2026)
Figure 64. South America Extended Release Drug Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Extended Release Drug Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Extended Release Drug Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Extended Release Drug Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Extended Release Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
世界の経口徐放性ドラッグデリバリー技術市場 2021：企業別、地域別、種類・用途別 The Oral Controlled Release Drug Delivery Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…- 世界の徐放性賦形剤市場 2021：企業別、地域別、種類・用途別 The Sustained Release Excipients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の徐放性注射剤市場 2021：企業別、地域別、種類・用途別 The Sustained Release Injectables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の徐放性農薬市場 2021：企業別、地域別、種類・用途別 The Slow and Controlled Release Pesticides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界の鋳造＆剥離紙市場 2021：企業別、地域別、種類・用途別 The Casting & Release Paper market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…